N-heterocycle substituted tryptamine derivatives and methods of using
US12338231B1 · kind B1 · utility
0Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2024 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Jun 24, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel N-heterocycle-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.